Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Hisse Senetlerindeki Sıralama #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Hisse Fiyatı
$0.05207079
Son senkronizasyon: 2023-11-15
Piyasa Değeri
$3.38M
Değişim (1 gün)
0.13%
Değişim (1 yıl)
0.00%
Ülke
AU
Ticaret Kazia Therapeutics Limited (KZA)

Kategori

Kazia Therapeutics Limited (KZA) için temettü verimi geçmişi
Kazia Therapeutics Limited (hisse sembolü: KZA) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Kazia Therapeutics Limited (KZA) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)